Granules Biocause Limited
Telangana
About Company
Description
Biotech pharmaceutical ingredients
Contact Information
Primary Phone
Primary Email
Website
Registered Address
State
Telangana
Country
India
Business Information
Business Types
Manufacturer
API Supplier
Manufacturing Units
1
Legal & Compliance
Certifications & Approvals
WHO-GMP
Not Certified
ISO
Not Certified
GMP
Not Certified
FSSAI
Not Certified
USFDA
Not Approved
EU-GMP
Not Certified
UK-MHRA
Not Approved
WHO Prequalified
No
PCD/Franchise Information
PCD Franchisor
No
Products
Total products: 25
| Product Name | Dosage Form | Composition | Therapeutic Category |
|---|---|---|---|
| API Type Synthetic chemistry Quality ICH Therapeutic Category Analgesic, Antipyretic Monograph Status USP-A, EP-A Granules Product Status Commercially Available Regulatory Filing/Technical Package US | Tablet | - | Analgesics |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Anti-ulcerative Monograph Status A Granules Product Status Not Available - DMF filled Regulatory Filing/Technical Package US DMF Innovator | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antibiotic Monograph Status NA Granules Product Status NA (Process validation under progress) Regulatory Filing/Technical Package US DMF I | Tablet | - | Antibiotics |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Anticancer Monograph Status IH Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF Innovator Brands | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Anticonvulsant Monograph Status A Granules Product Status Commercially Not Available Regulatory Filing/Technical Package US DMF Innovator | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antidepressant Monograph Status A Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF Innovator Bran | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antifungal Monograph Status USP-A, EP-A Granules Product Status Commercially Not Available Regulatory Filing/Technical Package US DMF, CEP | Tablet | - | Antifungals |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antihemorrhagics Monograph Status NA Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF Innovator B | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antihistamine Monograph Status A Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF Innovator Brand | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antihypertensive Monograph Status A Granules Product Status Not Available - DMF Filied Regulatory Filing/Technical Package US DMF Innovato | Tablet | - | Antihypertensives |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Antiretroviral Monograph Status NA Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF Innovator Bra | Capsule | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Expectorant Monograph Status A Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF Innovator Brands | Tablet | - | - |
| API Type Synthetic chemistry Quality ICH Therapeutic Category Muscle relaxant Monograph Status USP-A, EP-NA Granules Product Status Commercially Available Regulatory Filing/Technical Package US DMF, A | Tablet | - | - |
| Available dosage Form/Strength | Tablet | Tablet (12.5/25/50/75/100 mg), For Suspension,Oral... | - |
| Capabilities Facilities & Infrastructure Research & Development Reaction Capabilities Environment | - | - | Iron Supplements |
| Capabilities Facilities & Infrastructure Research & Development Reaction Capabilities Environment | - | - | Iron Supplements |
| Description Acetaminophen is a nonnarcotic analgesic and antipyretic drug. | - | - | Analgesics |
| Description Fluconazole is a synthetic triazole with antifungal activity. Fluconazole preferentially inhibits fungal cytochrome P-450 sterol C-14 alpha-demethylation, resulting in the accumulation of | - | - | Antifungals |
| Description Guaifenesin is a glyceryl guaiacolate with expectorant effects. Guaifenesin increases respiratory tract mucus secretions, acts as an irritant to gastric vagal receptors and recruits effere | - | - | Respiratory |
| Description Rifaximin is an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity. Rifaximin binds to the beta-subunit of bacterial DNA-depe | - | - | Antibiotics |
| Dosage Form | Tablet | Tablet (12.5/25/50/75/100mg),For suspension(12.5/2... | - |
| Environment | - | - | Iron Supplements |
| Environment | - | - | Iron Supplements |
| Granules Product Status | Vial | - | - |
| Innovator Brands | Capsule | - | - |
Social Media
Company Status
Status
Active
Verification
Verified
Statistics
Profile Views
65
Total Inquiries
0